Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
Abstract Background Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-relate...
Saved in:
Main Authors: | Ali Khosravi (Author), B. Jayaram (Author), Bahram Goliaei (Author), Ali Masoudi-Nejad (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A PheWAS study of a large observational epidemiological cohort of African Americans from the REGARDS study
by: Xueyan Zhao, et al.
Published: (2019) -
PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses
by: Qiu-Ju Han, et al.
Published: (2024) -
Genome-Wide Association Study (GWAS) of dental caries in diverse populations
by: Rasha N. Alotaibi, et al.
Published: (2021) -
Deep resequencing identifies candidate functional genes in leprosy GWAS loci.
by: Vinicius M Fava, et al.
Published: (2021) -
Functional validation of GWAS gene candidates for abnormal liver function during zebrafish liver development
by: Leah Y. Liu, et al.
Published: (2013)